Schedule 13D ownership disclosure

OYSTER POINT PHARMA INC

Security class unavailable · CUSIP: 69242L106

Event date: 2022-11-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
22.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-22-000647
Form type
SC 13D/A
Filer
New Enterprise Associates 14, L.P.
CIK
CIK 1544328
Filed
Nov 21, 2022
Reporting period
Nov 07, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub